Ahora viendo: Prof. Peter Sleight Dept of Cardiovascular Medicine Oxford, ... - 0:35
Prof. Peter Sleight Dept of Cardiovascular Medicine Oxford, UK, comments on the outcome of the TRANSCEND trial
The results of the TRANSCEND® trial demonstrate that telmisartan 80mg reduces the risk of cardiovascular death, myocardial infarction/heart
Registrate Ahora - Es Gratis
Enviar
Maximizar